Qingdao Haier Biomedical Co Ltd - Asset Resilience Ratio

Latest as of December 2025: 7.73%

Qingdao Haier Biomedical Co Ltd (688139) has an Asset Resilience Ratio of 7.73% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688139 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥447.59 Million

≈ $65.50 Million USD Cash + Short-term Investments

Total Assets

CN¥5.79 Billion

≈ $847.48 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Qingdao Haier Biomedical Co Ltd's Asset Resilience Ratio has changed over time. See 688139 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Qingdao Haier Biomedical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Qingdao Haier Biomedical Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥447.59 Million	7.73%
Total Liquid Assets	CN¥447.59 Million	7.73%

Asset Resilience Insights

Limited Liquidity: Qingdao Haier Biomedical Co Ltd maintains only 7.73% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Qingdao Haier Biomedical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Qingdao Haier Biomedical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Demant A/S CO:DEMANT	Medical Devices	-2.59%
Double Medical Technology Inc SHE:002901	Medical Devices	7.79%
Beijing Wandong Medical Technology Co Ltd SHG:600055	Medical Devices	4.92%
Sinocare Inc SHE:300298	Medical Devices	3.53%
MODULIGHT OY EO 1 F:78W	Medical Devices	22.31%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.39%
Theradiag SA PA:ALTHE	Medical Devices	15.59%
Nova EYE Medical Ltd AU:EYE	Medical Devices	11.08%

Annual Asset Resilience Ratio for Qingdao Haier Biomedical Co Ltd (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Qingdao Haier Biomedical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	7.73%	CN¥447.59 Million ≈ $65.50 Million	CN¥5.79 Billion ≈ $847.48 Million	-7.43pp
2024-12-31	15.16%	CN¥877.25 Million ≈ $128.37 Million	CN¥5.79 Billion ≈ $846.89 Million	+3.37pp
2023-12-31	11.78%	CN¥651.14 Million ≈ $95.28 Million	CN¥5.53 Billion ≈ $808.58 Million	-25.08pp
2022-12-31	36.87%	CN¥2.02 Billion ≈ $296.12 Million	CN¥5.49 Billion ≈ $803.21 Million	-6.60pp
2021-12-31	43.47%	CN¥2.13 Billion ≈ $311.65 Million	CN¥4.90 Billion ≈ $717.00 Million	+33.12pp
2020-12-31	10.35%	CN¥408.03 Million ≈ $59.71 Million	CN¥3.94 Billion ≈ $576.93 Million	+5.97pp
2019-12-31	4.38%	CN¥133.05 Million ≈ $19.47 Million	CN¥3.04 Billion ≈ $444.85 Million	--

pp = percentage points

About Qingdao Haier Biomedical Co Ltd

SHG:688139 China Medical Devices

Market Cap

$1.45 Billion

CN¥9.94 Billion CNY

Market Cap Rank

#7507 Global

#1816 in China

Share Price

CN¥31.40

Change (1 day)

-4.00%

52-Week Range

CN¥29.83 - CN¥36.98

All Time High

CN¥147.76